23andMe Holding Co (ticker: ME) is a consumer genetics and research company offering personalised genetic insights. It helps individuals access, understand, and benefit from the human genome. The company operates internationally.
23andMe Holding operates in the biotechnology and consumer genomics sectors and aims to build a unique research platform. This firm drives scientific discoveries and potential therapeutic developments based on comprehensive genetic and phenotypic data collected from its users.
Stay updated on ME's share price by adding it to your eToro watchlist.
This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.